A previous study reports that expression level of RCC2, RalA, and RalBP1 is significantly higher in DDP-resistant ovarian cancer cell lines compared to the DDP-sensitive tissues (Gong et al., 2019). This evidence concerns the gene RALA and ovarian carcinoma.